KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Accounts Payables: 2009-2025

Historic Accounts Payables for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $122.3 million.

  • Idexx Laboratories' Accounts Payables rose 10.54% to $122.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.3 million, marking a year-over-year increase of 10.54%. This contributed to the annual value of $114.2 million for FY2024, which is 3.22% up from last year.
  • Per Idexx Laboratories' latest filing, its Accounts Payables stood at $122.3 million for Q3 2025, which was up 4.87% from $116.6 million recorded in Q2 2025.
  • Idexx Laboratories' Accounts Payables' 5-year high stood at $127.3 million during Q2 2022, with a 5-year trough of $86.7 million in Q3 2021.
  • In the last 3 years, Idexx Laboratories' Accounts Payables had a median value of $116.6 million in 2025 and averaged $115.2 million.
  • In the last 5 years, Idexx Laboratories' Accounts Payables spiked by 55.77% in 2021 and then fell by 15.40% in 2023.
  • Idexx Laboratories' Accounts Payables (Quarterly) stood at $116.1 million in 2021, then dropped by 5.10% to $110.2 million in 2022, then grew by 0.38% to $110.6 million in 2023, then increased by 3.22% to $114.2 million in 2024, then grew by 10.54% to $122.3 million in 2025.
  • Its last three reported values are $122.3 million in Q3 2025, $116.6 million for Q2 2025, and $120.1 million during Q1 2025.